Order Article Reprints

Wattanavises S, Silsirivanit A, Sawanyawisuth K, Cha’on U, Waraasawapati S, Saentaweesuk W, Luang S, Chalermwat C, Wongkham C, Wongkham S. Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients. Medicina. 2019; 55(12):761. https://doi.org/10.3390/medicina55120761

Wattanavises, Sasiprapa, Atit Silsirivanit, Kanlayanee Sawanyawisuth, Ubon Cha’on, Sakda Waraasawapati, Waraporn Saentaweesuk, Sukanya Luang, Chalongchai Chalermwat, Chaisiri Wongkham, and Sopit Wongkham. 2019. "Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients" Medicina 55, no. 12: 761. https://doi.org/10.3390/medicina55120761

Wattanavises, S., Silsirivanit, A., Sawanyawisuth, K., Cha’on, U., Waraasawapati, S., Saentaweesuk, W., Luang, S., Chalermwat, C., Wongkham, C., & Wongkham, S. (2019). Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients. Medicina, 55(12), 761. https://doi.org/10.3390/medicina55120761